Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Puma Biotechnology Stock (NASDAQ: PBYI) stock price, news, charts, stock research, profile.
Open | $2.62 |
Close | - |
Volume / Avg. | 116.18K / 476.20K |
Day Range | $2.49 - $2.62 |
52 Wk Range | 2.13 - 7.73 |
Market Cap | $123.97M |
P/E Ratio | 13.63 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 8.52% |
Days to Cover | 9.14 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Puma Biotechnology (NASDAQ:PBYI) through any online brokerage.
Other companies in Puma Biotechnology’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Anixa Biosciences (NASDAQ:ANIX), Citius Oncology (NASDAQ:CTOR), Adicet Bio (NASDAQ:ACET) and Agenus (NASDAQ:AGEN).
Puma Biotechnology has a consensus price target of $7.00.
The stock price for Puma Biotechnology (NASDAQ: PBYI) is $2.57 last updated September 23, 2024 at 12:40 PM EDT.
There are no upcoming dividends for Puma Biotechnology.
Puma Biotechnology’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Puma Biotechnology.
Puma Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.